0.6668
Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
3.02%
3.5081
|
3.4052 | 4.2028 | 4.3498 | 4.6519 |
| Depreciation and Amortization |
2.65%
0.00375
|
0.00385 | 0.0041 | 0.0041 | 0.0045 |
| Operating Income/Loss |
3.02%
-3.5081
|
-3.4052 | -4.2028 | -4.3498 | -4.6519 |
| Net Income/Loss |
112.43%
-7.0721
|
-3.3292 | -4.0742 | -4.1774 | -4.331 |
| Basic Average Shares |
10.40%
12.42
|
11.25 | - | 10.83 | 10.78 |
| Diluted Average Shares |
10.40%
12.42
|
11.25 | - | 10.83 | 10.78 |
| Basic Earnings Per Share |
90.00%
-0.57
|
-0.30 | - | -0.39 | -0.40 |
| Diluted Earnings Per Share |
90.00%
-0.57
|
-0.30 | - | -0.39 | -0.40 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):